Login / Signup

Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success?

Natalia GeorgantzoglouStefania KokkaliGerasimos TsourouflisStamatios Theocharis
Published in: Cancers (2021)
Adrenocortical carcinoma is a rare malignancy with aggressive behavior, with up to 40% of patients presenting with metastases at the time of diagnosis. Both conventional chemotherapeutic regimens and novel immunotherapeutic agents, many of which are currently being tested in ongoing clinical trials, have yielded modest results so far, bringing the need for a deeper understanding of adrenal cancer behavior to the forefront. In the recent years, the tumor microenvironment has emerged as a major determinant of cancer response to immunotherapy and an increasing number of studies on other solid tumors have focused on manipulating the microenvironment in the favor of the host and discovering new potential target molecules. In the present review we aim to explore the characteristics of adrenocortical cancer's microenvironment, highlighting the mechanisms of immune evasion responsible for the modest immunotherapeutic results, and identify novel potential strategies.
Keyphrases
  • papillary thyroid
  • clinical trial
  • squamous cell
  • stem cells
  • lymph node metastasis
  • childhood cancer
  • human health